GPC1 is a GPI-anchored heparan sulfate proteoglycan that is overexpressed in several cancers, including pancreatic cancer and CRC, and exosomal GPC1 in the plasma is reported to be a sensitive and specific biomarker for the early detection of pancreatic cancer22,23. This evidence concerns the gene CD44 and familial pancreatic carcinoma.